AOD-9604 vs Semaglutide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

AOD-9604 and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares AOD-9604 and Semaglutide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AOD-9604Semaglutide
CategoryWeight Management & MetabolicWeight Management & Metabolic
Regulatory status (US)Research use onlyFDA approved
Typical dosage300 mcg0.25-2.4 mg
Frequencydailyweekly
Reported benefitsFat metabolism, body composition improvement, no impact on blood sugar, cartilage repairSignificant weight loss, improved blood sugar control, reduced cardiovascular risk, appetite suppression
Reported side effectsMinimal side effects reportedNausea, vomiting, diarrhea, constipation, potential pancreatitis risk

Key differences

Primary use. AOD-9604 is categorised under Weight Management & Metabolic, while Semaglutide falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. AOD-9604: not FDA-approved; treated as a research compound. Semaglutide: FDA-approved.

Dosing. AOD-9604 is typically dosed at 300 mcg (daily). Semaglutide is typically dosed at 0.25-2.4 mg (weekly).

Can you stack them?

Some protocols combine peptides, but stacking AOD-9604 and Semaglutide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between AOD-9604 and Semaglutide?
AOD-9604 and Semaglutide are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. AOD-9604 is not FDA-approved; generally classified as a research compound, whereas Semaglutide is FDA-approved for one or more indications.
What is AOD-9604 used for?
Fat loss, metabolic enhancement.
What is Semaglutide used for?
Weight loss, blood sugar control.
Can you take AOD-9604 and Semaglutide together?
Some users combine peptides within a single protocol, but stacking AOD-9604 and Semaglutide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is AOD-9604 or Semaglutide FDA-approved?
AOD-9604 is not FDA-approved; generally classified as a research compound. Semaglutide is FDA-approved for one or more indications.

Read the full articles

  • AOD-9604 — full monograph: mechanism, research, dosing & references
  • Semaglutide — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

← All peptide comparisons